< Resources

Webinar

Genomic Variant Interpretation Raising the Bar for Speed and Accuracy Through Data Curation and Reporting

GenomOncology’s VP of Product Innovation, Matthew Stachowiak, and Genomenon’s Senior Manager of Customer Success, Denice Belandres, will demonstrate how GenomOncology’s reporting capabilities combined with Genomenon’s data, powers a new standard in genomic variant interpretation for clinical labs.

What You’ll Learn:

  • How real-time, AI-indexed evidence—spanning over 27 million variants and 10 million full-text articles—and expertly curated content, following ACMG guidelines, facilitate in-depth variant-level analysis, helping labs surface critical insights missed by standard tools and reduce curation time.
  • How Genomenon’s Mastermind Flex Data seamlessly integrates into lab workflows to accelerate VUS resolution, enhance diagnostic confidence, and raise the bar for clinical accuracy, speed, and scalability.
  • How somatic variant data from Genomenon’s Cancer Knowledgebase (CKB) is leveraged by partners like GenomOncology to enhance cancer interpretation—ensuring both germline and somatic pipelines benefit from the most comprehensive, real-time genomic evidence available.

SPEAKERS
Denice Belandres
Senior Manager of Customer Success

Denice provides technical support and training to Mastermind users at all levels. With a background in germline variant analysis and preimplantation genetics in clinical NGS labs, she turns feedback into function, enabling implementation of Mastermind for a variety of clinical use-cases.

The World’s Most Comprehensive Source of Genomic Evidence

Mastermind accelerates variant interpretation with immediate insight into the full text of millions of scientific articles. Prioritize your search results by clinical relevance and find what you are looking for 5-10 times faster

Explore Mastermind CORE
The Most Comprehensive Source of Curated Genomic Evidence + Scientific Experts

We help provide insights into key genetic drivers of diseases and relevant biomarkers. By working together to understand this data, we enable scientists and researchers to make more informed decisions on programs of interest. To learn more about how we can partner together to find your genomic variant solutions, we invite you to click on the link below.

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.